Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZAI LAB LIMITED

(ZLAB)
  Report
Delayed Quote. Delayed Nasdaq - 09/17 04:00:00 pm
128.64 USD   +1.78%
09:11aINSIDER SELL : Zai Lab
MT
09/16ZAI LAB : Launches Operations in Cambridge
MT
09/16ZAI LAB : Expands U.S. Operations to Join the Cambridge Biotechnology Community
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zai Lab Prices Share Offering for Hong Kong, New York

04/21/2021 | 06:35am EDT


© MT Newswires 2021
All news about ZAI LAB LIMITED
09:11aINSIDER SELL : Zai Lab
MT
09/16ZAI LAB : Launches Operations in Cambridge
MT
09/16ZAI LAB : Expands U.S. Operations to Join the Cambridge Biotechnology Community
AQ
09/15ZAI LAB : ADRs Fall; Cancer Treatment Won Breakthrough Therapy Designation in Ch..
MT
09/14ZAI LAB : Bemarituzumab Receives Breakthrough Therapy Designation in China
MT
09/14ZAI LAB : Announces Breakthrough Therapy Designation Granted for Bemarituzumab (..
AQ
09/09INSIDER SELL : Zai Lab
MT
09/09ZAI LAB : to Host Virtual Research and Development Day on September 22, 2021
AQ
09/07INSIDER SELL : Zai Lab
MT
08/25ZHONGCHAO INC. : Expands Patient Management Business to Ovarian Cancer Market
PR
More news
Analyst Recommendations on ZAI LAB LIMITED
More recommendations
Financials (USD)
Sales 2021 155 M - -
Net income 2021 -535 M - -
Net cash 2021 1 473 M - -
P/E ratio 2021 -19,4x
Yield 2021 -
Capitalization 12 273 M 12 273 M -
EV / Sales 2021 69,5x
EV / Sales 2022 31,8x
Nbr of Employees 1 194
Free-Float 98,9%
Chart ZAI LAB LIMITED
Duration : Period :
Zai Lab Limited Technical Analysis Chart | ZLAB | US98887Q1040 | MarketScreener
Technical analysis trends ZAI LAB LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 126,39 $
Average target price 211,57 $
Spread / Average Target 67,4%
EPS Revisions
Managers and Directors
Ying Du Chairman & Chief Executive Officer
Tao Fu President, Chief Operating Officer & Director
Billy Cho Chief Financial Officer
Ning Xu Executive VP & Head-Clinical Operations
James Yan Chief Operating Officer-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
ZAI LAB LIMITED-6.61%12 059
CSL LIMITED9.25%102 325
WUXI BIOLOGICS (CAYMAN) INC.19.75%63 410
SAMSUNG BIOLOGICS CO.,LTD.12.95%51 545
BIOGEN INC.22.20%44 664
ALEXION PHARMACEUTICALS, INC.0.00%40 336